With increasing pressure on pharmaceutical organisations to cut costs and streamline processes, many are deciding to outsource clinical trials. In the current economic climate, outsourcers can provide a key way to continue drug development and trials without incurring the associated costs. Most successful drugs carry the burden of attrition – those that have failed in late stages or in clinical trials. For some, outsourcing clinical trials is the answer.
|
|
Have Your Say Rate this feature and give us your feedback in the comments section below |